Summary
Johnson & Johnson (JNJ) has announced a significant addition to its Board of Directors with the election of John Morikis, effective September 8, 2025. Mr. Morikis brings extensive leadership experience, having served as Executive Chairman, President, and CEO of The Sherwin-Williams Company from 2016 to 2024, with a career spanning nearly forty years at the company. His appointment is expected to enhance the Board's expertise, particularly given his significant tenure in executive roles. Mr. Morikis has been assigned to key committees, including the Audit Committee and the Compensation & Benefits Committee, indicating his immediate and strategic role within the company's governance. His compensation as a non-employee director will align with the standard practices outlined in JNJ's 2025 Proxy Statement.
Key Highlights
- 1John Morikis elected to Johnson & Johnson's Board of Directors, effective September 8, 2025.
- 2Mr. Morikis is an independent director, meeting NYSE Listed Company Manual requirements.
- 3He will serve on the Audit Committee and the Compensation & Benefits Committee.
- 4Mr. Morikis possesses extensive leadership experience, having been Executive Chairman, President, and CEO of The Sherwin-Williams Company (2016-2024).
- 5His career at Sherwin-Williams spanned from 1984, including roles as Division President and Group President.
- 6Compensation for Mr. Morikis as a non-employee director will follow the 2025 Proxy Statement's disclosed rates.
- 7The announcement was made via a press release filed as an exhibit to the 8-K.